venetoclax治疗-话题@MedSci

#venetoclax治疗#

4篇内容 | 783人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1419617, encodeId=3ba7141961e27, content=<a href='/topic/show?id=1f35183e7da' target=_blank style='color:#2F92EE;'>#venetoclax治疗#</a>, objectTitle=NEJM：Venetoclax治疗急性髓性白血病（AML），III期临床取得正面结果, objectType=article, longId=199491, objectId=6d08199491a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d08199491a0, replyNumber=0, likeNumber=37, createdTime=2020-08-16, rootId=0, userName=wleon8896, userId=71a93510067, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d08199491a0, moduleTitle=NEJM：Venetoclax治疗急性髓性白血病（AML），III期临床取得正面结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d08199491a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1419616, encodeId=33e21419616f3, content=<a href='/topic/show?id=1f35183e7da' target=_blank style='color:#2F92EE;'>#venetoclax治疗#</a>, objectTitle=Blood：影响venetoclax治疗CLL的疗效的因素, objectType=article, longId=165121, objectId=7b7716512115, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b7716512115, replyNumber=0, likeNumber=32, createdTime=2019-04-29, rootId=0, userName=wleon8896, userId=71a93510067, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b7716512115, moduleTitle=Blood：影响venetoclax治疗CLL的疗效的因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b7716512115)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1419615, encodeId=63d51419615b6, content=<a href='/topic/show?id=1f35183e7da' target=_blank style='color:#2F92EE;'>#venetoclax治疗#</a>, objectTitle=NEJM：venetoclax治疗复发慢性淋巴细胞性白血病初见成效, objectType=article, longId=60349, objectId=43666034930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43666034930, replyNumber=0, likeNumber=38, createdTime=2015-12-08, rootId=0, userName=wleon8896, userId=71a93510067, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43666034930, moduleTitle=NEJM：venetoclax治疗复发慢性淋巴细胞性白血病初见成效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43666034930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1419614, encodeId=93441419614a8, content=<a href='/topic/show?id=1f35183e7da' target=_blank style='color:#2F92EE;'>#venetoclax治疗#</a>, objectTitle=ASH 2014：venetoclax治疗AML的II期研究数据公布, objectType=article, longId=44370, objectId=4a7c443e0bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a7c443e0bd, replyNumber=0, likeNumber=35, createdTime=2014-12-24, rootId=0, userName=wleon8896, userId=71a93510067, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a7c443e0bd, moduleTitle=ASH 2014：venetoclax治疗AML的II期研究数据公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a7c443e0bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

venetoclax治疗

2020-05-29

wleon8896 (审核中...)

前往app查看评论内容

#venetoclax治疗#

NEJM：Venetoclax治疗急性髓性白血病（AML），III期临床取得正面结果

2020-08-16

wleon8896 (审核中...)

前往app查看评论内容

#venetoclax治疗#

Blood：影响venetoclax治疗CLL的疗效的因素

2019-04-29

wleon8896 (审核中...)

前往app查看评论内容

#venetoclax治疗#

NEJM：venetoclax治疗复发慢性淋巴细胞性白血病初见成效

2015-12-08

wleon8896 (审核中...)

前往app查看评论内容

#venetoclax治疗#

ASH 2014：venetoclax治疗AML的II期研究数据公布

2014-12-24

科室
- - 订阅+
  - 更多科室
工具
服务